secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alpha Cognition Inc. (ACOG)
CIK:        0001655923
Form:       8-K
Filed at:   2025-10-02T23:59:59+00:00
Accession:  0001213900-25-094911
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alpha Cognition prices $35M oversubscribed public offering at $6.25/share
-------------------------------------------------------------------------

- Gross proceeds of ~$35M from 5.6M shares (incl. pre-funded warrants) at $6.25 per share.
- Offering was oversubscribed; led by premier healthcare-dedicated investor and large existing shareholders.
- Expected to close Oct 2, 2025; underwriter has 30-day option to purchase up to 840K additional shares.
- Net proceeds to accelerate commercial launch of ZUNVEYL (Benzgalantamine) for Alzheimer's disease.
- Company expects total cash position of approximately $70 million following the closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1655923/000121390025094911/0001213900-25-094911-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1655923/000121390025094911/ea0259660-8k_alpha.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-094911

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer